142 related articles for article (PubMed ID: 14718360)
1. Role for thromboxane receptors in angiotensin-II-induced hypertension.
Francois H; Athirakul K; Mao L; Rockman H; Coffman TM
Hypertension; 2004 Feb; 43(2):364-9. PubMed ID: 14718360
[TBL] [Abstract][Full Text] [Related]
2. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response.
Kawada N; Dennehy K; Solis G; Modlinger P; Hamel R; Kawada JT; Aslam S; Moriyama T; Imai E; Welch WJ; Wilcox CS
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F753-9. PubMed ID: 15213069
[TBL] [Abstract][Full Text] [Related]
3. A role for the thromboxane receptor in L-NAME hypertension.
Francois H; Makhanova N; Ruiz P; Ellison J; Mao L; Rockman HA; Coffman TM
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1096-102. PubMed ID: 18684890
[TBL] [Abstract][Full Text] [Related]
4. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
[TBL] [Abstract][Full Text] [Related]
5. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.
Zimmerman MC; Lazartigues E; Sharma RV; Davisson RL
Circ Res; 2004 Jul; 95(2):210-6. PubMed ID: 15192025
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
[TBL] [Abstract][Full Text] [Related]
7. Rapid development of severe end-organ damage in C57BL/6 mice by combining DOCA salt and angiotensin II.
Kirchhoff F; Krebs C; Abdulhag UN; Meyer-Schwesinger C; Maas R; Helmchen U; Hilgers KF; Wolf G; Stahl RA; Wenzel U
Kidney Int; 2008 Mar; 73(5):643-50. PubMed ID: 18033241
[TBL] [Abstract][Full Text] [Related]
8. Deletion of vascular thromboxane A
Braun H; Hauke M; Petermann M; Eckenstaler R; Ripperger A; Schwedhelm E; Ludwig-Kraus B; Bernhard Kraus F; Jalal Ahmed Shawon M; Dubourg V; Zernecke A; Schreier B; Gekle M; Benndorf RA
Biochem Pharmacol; 2024 Jan; 219():115916. PubMed ID: 37979705
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.
Michel F; Silvestre JS; Waeckel L; Corda S; Verbeuren T; Vilaine JP; Clergue M; Duriez M; Levy BI
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):488-93. PubMed ID: 16385086
[TBL] [Abstract][Full Text] [Related]
10. COX-2-dependent cardiac failure in Gh/tTG transgenic mice.
Zhang Z; Vezza R; Plappert T; McNamara P; Lawson JA; Austin S; Praticò D; Sutton MS; FitzGerald GA
Circ Res; 2003 May; 92(10):1153-61. PubMed ID: 12702643
[TBL] [Abstract][Full Text] [Related]
11. The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background.
Facemire CS; Griffiths R; Audoly LP; Koller BH; Coffman TM
Hypertension; 2010 Feb; 55(2):531-8. PubMed ID: 20065147
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death.
Sparks MA; Makhanova NA; Griffiths RC; Snouwaert JN; Koller BH; Coffman TM
Hypertension; 2013 Jan; 61(1):166-73. PubMed ID: 23150508
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats.
Wu R; Laplante MA; de Champlain J
Hypertension; 2005 Jun; 45(6):1139-44. PubMed ID: 15851630
[TBL] [Abstract][Full Text] [Related]
14. CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice.
Coles B; Lewis R; Anning PB; Morton J; Baalasubramanian S; Morgan BP; O'Donnell VB
Immunology; 2007 Aug; 121(4):518-25. PubMed ID: 17433074
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
16. Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.
Bouabout G; Ayme-Dietrich E; Jacob H; Champy MF; Birling MC; Pavlovic G; Madeira L; Fertak LE; Petit-Demoulière B; Sorg T; Herault Y; Mudgett J; Monassier L
Arch Cardiovasc Dis; 2018 Jan; 111(1):41-52. PubMed ID: 29113787
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.
Jennings BL; Sahan-Firat S; Estes AM; Das K; Farjana N; Fang XR; Gonzalez FJ; Malik KU
Hypertension; 2010 Oct; 56(4):667-74. PubMed ID: 20805442
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology.
Khan NS; Song CY; Jennings BL; Estes AM; Fang XR; Bonventre JV; Malik KU
Hypertension; 2015 Apr; 65(4):784-92. PubMed ID: 25667212
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice.
Boffa JJ; Just A; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 2004 Sep; 15(9):2358-65. PubMed ID: 15339984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
